BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:38 PM
 | 
Jun 29, 2007
 |  BC Extra  |  Company News

Karo Bio delays development of KB5359

Karo Bio (SSE:KARO) said it would delay development of its preclinical compound KB5359 to treat dyslipidemia...

Read the full 61 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >